Mizuho's Jared Holz joins 'Fast Money' to talk the future of UnitedHealth after the stock slides on news of DOJ probe.

Mizuho has acquired independent European financial advisory firm Augusta as the financial services group looks to boost its M ...

Investing.com -- Mizuho launched coverage of Teladoc (NYSE: TDOC) Health with a Neutral rating and $10 price target, flagging the company’s steady growth in Integrated Care but cautioning that ...

Investing.com -- Mizuho upgraded Global Payments (NYSE: GPN) to Outperform on the potential for a material earnings re-rating driven by cost synergies from the Worldpay acquisition and accelerating ...

Wood, who helped build Edwards’ TAVR business, will become CEO of Procept BioRobotics. Edwards also raised its sales and ...

The rapid rise in companies adopting Bitcoin treasury strategies is starting to dilute the scarcity premium once enjoyed by early movers such as Strategy Inc., according to a note from Mizuho analysts ...

In a report released today, Vijay Rakesh from Mizuho Securities maintained a Buy rating on Tesla, with a price target of $375.00. The company’s shares closed today at $332.56. Take advantage of ...

As the window to seal a trade deal with the U.S. closes, analysts say Washington has its reasons to finalize an agreement ...

UnitedHealth stock slips as the health insurer confirms DOJ’s investigation into its Medicare billing practices. Mizuho analyst says it’s not a shock for UNH shares.

It’s pretty shocking just how poorly the health insurance names are trading. Centene–a major Obamacare and Medicaid ...

Mizuho upgraded Global Payments (GPN) to Outperform from Neutral with a price target of $114, up from $86. The company’s increased scale following ...

RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics on July 22 and set a price target of $184.00. The company’s shares closed yesterday at $106.36. Take advantage of ...